Peptic ulcer disease
- 24 February 2017
- journal article
- review article
- Published by Elsevier BV in The Lancet
- Vol. 390 (10094), 613-624
- https://doi.org/10.1016/s0140-6736(16)32404-7
Abstract
No abstract availableKeywords
This publication has 99 references indexed in Scilit:
- Helicobacter pylori-induced gastric inflammation and gastric cancerCancer Letters, 2014
- Vascular and upper gastrointestinal effects of non-steroidal anti-inflammatory drugs: meta-analyses of individual participant data from randomised trialsThe Lancet, 2013
- Comorbidities Affect Risk of Nonvariceal Upper Gastrointestinal BleedingGastroenterology, 2013
- GI-REASONS: A Novel 6-Month, Prospective, Randomized, Open-Label, Blinded Endpoint (PROBE) TrialThe American Journal of Gastroenterology, 2013
- Management ofHelicobacter pyloriinfection—the Maastricht IV/ Florence Consensus ReportGut, 2012
- Proton Pump Inhibitors Exacerbate NSAID-Induced Small Intestinal Injury by Inducing DysbiosisGastroenterology, 2011
- The association of vacA genotype and Helicobacter pylori-related disease in Latin American and African populationsClinical Microbiology & Infection, 2009
- Endoscopic clipping versus injection and thermo-coagulation in the treatment of non-variceal upper gastrointestinal bleeding: a meta-analysisGut, 2007
- Risk of upper gastrointestinal ulcer bleeding associated with selective cyclo-oxygenase-2 inhibitors, traditional non-aspirin non-steroidal anti-inflammatory drugs, aspirin and combinationsGut, 2006
- Interleukin-1 polymorphisms associated with increased risk of gastric cancerNature, 2000